Agriculture, Rural Development, and Related Agencies Appropriations for 1982: Hearings Before a Subcommitee of the Committee on Appropriations, House of Representatives, Ninety-sixth Congress, First Session, Parts 5-6U.S. Government Printing Office, 1981 - United States |
From inside the book
Results 1-5 of 100
Page 26
... prepared by American Cyanamid but you refused any further action to change the tolerances or the action levels until the long - term studies are complete . The results of these studies will not be available for three years . Now ...
... prepared by American Cyanamid but you refused any further action to change the tolerances or the action levels until the long - term studies are complete . The results of these studies will not be available for three years . Now ...
Page 29
... prepared to present the available SSPE data and the new protocol to our Neu- rology Advisory Committee . [ The information follows : ] [ From the Wall Street Journal , Sept. 19 , 1979 ] FIRM BLASTS FDA'S REQUEST TO WITHHOLD ...
... prepared to present the available SSPE data and the new protocol to our Neu- rology Advisory Committee . [ The information follows : ] [ From the Wall Street Journal , Sept. 19 , 1979 ] FIRM BLASTS FDA'S REQUEST TO WITHHOLD ...
Page 36
... prepare for this meet- ing . Mr. HIGHTOWER . Has FDA tried in any manner to change data requirements and regulatory ... prepared and widely distributed in 1979 which described the general nature and scope of the intended revisions . A ...
... prepare for this meet- ing . Mr. HIGHTOWER . Has FDA tried in any manner to change data requirements and regulatory ... prepared and widely distributed in 1979 which described the general nature and scope of the intended revisions . A ...
Page 37
... prepared to give you a view on whether it ought to be approved by the committee , but I certainly cannot see any objec- tion at all to having some informed discussion before a congression- al committee and having all facets of an issue ...
... prepared to give you a view on whether it ought to be approved by the committee , but I certainly cannot see any objec- tion at all to having some informed discussion before a congression- al committee and having all facets of an issue ...
Page 38
... prepared freshly ; that there was a genuine danger of serious eye infection with the system then in use . I did my own review of the circumstances with my own staff , and I could not take any exception based on the record available to ...
... prepared freshly ; that there was a genuine danger of serious eye infection with the system then in use . I did my own review of the circumstances with my own staff , and I could not take any exception based on the record available to ...
Other editions - View all
Common terms and phrases
action activities additional aflatoxin agency agency's amended ampicillin analysis analyzed animal drugs appropriate approval approximately benzodiazepines blood budget Bureau carcinogen chemical cimetidine clinical Committee commodities compliance Conduct consumer contamination cosmetic costs determine digoxin dispensers distribution dose Drug Administration Drug Applications effects established Estimated evaluation facilities FDA's Federal Register feed Food and Drug Food Safety FSQS funds HOUSTON human implementation increase industry initial inspection investigations laboratory manufacturers meat and poultry medical devices ment methods methoxsalen million monitoring NOVITCH orphan drugs patient package inserts percent personnel pesticide petition pharmacists pharmacy phenytoin potential POULTRY PRODUCTS PPIs prescription drug problems procedures proposed radiation regulations regulatory reports request requirements response revised risk samples scientific September 12 Service SODIUM specific standards submitted testing thiazide tion toxic Toxicology USDA vaccines warfarin WHITTEN